Amsterdam UMC, The Netherlands

Primary Supervisor MIRACLE Research Projects:

DC1: Optimizing treatment decisions by using MRD data combined with artificial intelligence >

DC4: Characterization of AML MRD using single cell transcriptomic and epigenetic analysis >

Charles University, Czech Republic

Primary Supervisor MIRACLE Research Project:

DC02: In-depth analysis of phenotypic acute leukemia MRD dynamics using single sell data and advance computational techniques >

Goethe University Frankfurt, Germany

Primary Supervisor MIRACLE Research Project:

DC09: Characterization of persisting leukemic blasts in down syndrome patients to define targets for immune-therapy >

INSERM, France

Primary Supervisor MIRACLE Research Project:

DC06: Multiomic and metabolomic characterization of AML residual disease after AZA/VEN treatment >

Ludwig, Maximilians University Munich, Germany

Primary Supervisor MIRACLE Research Project:

DC10: Targeting MRD and LSCs in the bone marrow niche by chemokine modified, dual targeting CAR T cells in AML >

MIMETAS, The Netherlands

Primary Supervisor MIRACLE Research Project:

DC03: The establishment of clinical translational AML MRD on-chip models >

Ospedale San Raffaele, Italy

Primary Supervisor MIRACLE Research Project:

DC08: Therapy-induced senescence as anti-cancer and immune-stimulatory strategy in AML >

Universidad de Sevilla, Spain

Primary Supervisor MIRACLE Research Project:

DC07: Dissecting and targeting niche-dependent vulnerabilities of protection from therapy in AML >

VIB-KU Leuven Center for Cancer Biology, Belgium

Primary Supervisor MIRACLE Research Project:

DC05: Characterization of acute lymphoblastic leukemia MRD and relapse using single cell omics >
            

Active Motif, Belgium

Brain & Body Company, The Netherlands

European Hematology Association, The Netherlands

Fundament, The Netherlands

Hematon, The Netherlands

IBSAL, Belgium

Innovation Exchange Amsterdam, The Netherlands

KU Leuven, Belgium

Ortec, The Netherlands

Co-Supervisor MIRACLE Research Projects:

DC1: Optimizing treatment decisions by using MRD data combined with artificial intelligence >

Proefdiervrij, The Netherlands

Somesault 18:24, Belgium

University of Cambridge, United Kingdom

Universitätsklinikum Frankfurt, Germany

Universita Vita-Salute San Raffaele, Italy

Vrije Universiteit Amsterdam, The Netherlands